Executive Insights Into CMO Selection: Greg Troiano, BIND Biosciences

By Rob Wright

Life Science Leader magazine put together an executive roundtable article on the CMO selection process for a 2011 special supplement. The intent — to gain a better understanding of the some of the challenges faced during the partnering and provide insights on how to overcome. I received some great responses from Greg Troiano, sr. staff engineer, process development at BIND Biosciences. Prior to joining BIND, Troiano was Associate Director of Process Development at Alkermes, where he lead a team of managers, engineers, and technicians to develop, optimize, commercialize, and scale up microsphere and other drug delivery technologies. Among the products he helped develop are Nutropin Depot®, Risperdal Consta®, Vivitrol®, and Exenatide LARTM. Prior to Alkermes, he was an engineer at Guilford Pharmaceuticals, where he helped commercialize Gliadel® Wafer and develop a process for PaclimerTM paclitaxel microspheres. Troiano has over 10 process and equipment patents/applications and has published multiple scientific articles on drug delivery.